Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 24510725)

1.

Flow cytometry-based cytotoxicity and antibody binding assay.

Alheim M.

Curr Protoc Cytom. 2013 Oct 9;66:Unit 6.34.. doi: 10.1002/0471142956.cy0634s66.

PMID:
24510725
2.

Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.

AlMahri A, Holgersson J, Alheim M.

Tissue Antigens. 2012 Nov;80(5):404-15. doi: 10.1111/j.1399-0039.2012.01954.x. Epub 2012 Aug 30.

PMID:
22931381
3.

Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.

Saw CL, Bray RA, Gebel HM.

Cytometry B Clin Cytom. 2008 Sep;74(5):287-94. doi: 10.1002/cyto.b.20424.

4.

Evaluation of a new flow cytometry crossmatch procedure for simultaneous detection of cytotoxicity and antibody binding.

Alheim M, Paul PK, Hauzenberger DM, Wikström AC.

Tissue Antigens. 2013 Aug;82(2):125-30. doi: 10.1111/tan.12151. Epub 2013 Jun 17.

PMID:
23772862
5.
6.

Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.

Thammanichanond D, Athimang W, Paisooksantivatana K, Mongkolsuk T, Ingsathit A, Worawichawong S, Kitpoka P, Jirasiritham S, Kantachuvesiri S.

Transplant Proc. 2012 Jan;44(1):62-5. doi: 10.1016/j.transproceed.2011.11.024.

PMID:
22310580
7.

Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.

Karpinski M, Rush D, Jeffery J, Exner M, Regele H, Dancea S, Pochinco D, Birk P, Nickerson P.

J Am Soc Nephrol. 2001 Dec;12(12):2807-14.

8.

Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.

Delgado JC, Eckels DD.

Exp Mol Pathol. 2008 Aug;85(1):59-63. doi: 10.1016/j.yexmp.2008.03.009. Epub 2008 Apr 10. Review.

PMID:
18499103
9.

Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.

Kute VB, Vanikar AV, Gumber MR, Trivedi VB, Shah PR, Patel HV, Balwani MR, Modi PR, Trivedi HL.

Ren Fail. 2013 Aug;35(7):1027-30. doi: 10.3109/0886022X.2013.810539. Epub 2013 Jul 5.

PMID:
23829775
10.

Clinical cytometry and progress in HLA antibody detection.

Bray RA, Tarsitani C, Gebel HM, Lee JH.

Methods Cell Biol. 2011;103:285-310. doi: 10.1016/B978-0-12-385493-3.00012-7. Review.

PMID:
21722808
11.

Luminex and antibody detection in kidney transplantation.

Picascia A, Infante T, Napoli C.

Clin Exp Nephrol. 2012 Jun;16(3):373-81. doi: 10.1007/s10157-012-0635-1. Epub 2012 May 3. Review.

PMID:
22552384
12.

[C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.

Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, Körmöczi G, Böhmig GA.

Hum Immunol. 2005 May;66(5):526-34. Epub 2005 Feb 12.

PMID:
15935890
13.

Complement-dependent cytotoxicity crossmatch.

Peña JR, Fitzpatrick D, Saidman SL.

Methods Mol Biol. 2013;1034:257-83. doi: 10.1007/978-1-62703-493-7_13.

PMID:
23775741
14.

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.

Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.

Transplantation. 2013 Jan 15;95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc.

PMID:
23238534
15.

Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.

Abdel Rahman AS, Fahim NM, El Sayed AA, El Hady SA, Ahmad YS.

Egypt J Immunol. 2005;12(2):77-89.

PMID:
17977213
16.

Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.

Norin AJ, Mondragon-Escorpizo MO, Brar A, Hochman D, Sumrani N, Distant DA, Salifu MO.

Hum Immunol. 2013 Oct;74(10):1304-12. doi: 10.1016/j.humimm.2013.06.027. Epub 2013 Jun 27.

PMID:
23811689
17.

The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch results.

Graff RJ, Buchanan PM, Dzebisashvili N, Schnitzler MA, Tuttle-Newhall J, Xiao H, Schadde E, Gheorghian A, Lentine KL.

Transplant Proc. 2010 Nov;42(9):3471-4. doi: 10.1016/j.transproceed.2010.06.025.

PMID:
21094799
18.

Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.

Lenaers JI, Christiaans MH, Voorter CE, van Hooff HP, van den Berg-Loonen EM.

Transplantation. 2006 Nov 15;82(9):1142-7.

PMID:
17102764
19.

Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.

Zieliński M, Zielińska H, Moszkowska G, Dȩbska-Ślizień A, Rutkowski B, Trzonkowski P.

Transplant Proc. 2013 Jan-Feb;45(1):88-94. doi: 10.1016/j.transproceed.2012.10.029.

PMID:
23375279
20.

For anti-HLA-specific donor antibodies detection by flow cytometry cytotoxic crossmatches comparison of methods.

Cervelli C, Pisani F, Aureli A, Azzarone R, Scimitarra M, Battistoni C, Di Iulio B, Fracassi D, Scarnecchia MA, Famulari A, Papola F.

Transplant Proc. 2013 Sep;45(7):2761-4. doi: 10.1016/j.transproceed.2013.07.023.

PMID:
24034042
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk